Next Article in Journal
Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils
Next Article in Special Issue
Evolution and Virulence of Influenza A Virus Protein PB1-F2
Previous Article in Journal
Transcriptome-Wide Identification and Characterization of Potato Circular RNAs in Response to Pectobacterium carotovorum Subspecies brasiliense Infection
Previous Article in Special Issue
Molecular Markers for Interspecies Transmission of Avian Influenza Viruses in Mammalian Hosts
Open AccessReview

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective

Department of Animal Sciences, University of Florida, Gainesville, FL 32611, USA
College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA
Diagnostic Medicine/Pathobiology and Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Manhattan, KS 66502, USA
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(1), 68;
Received: 13 December 2017 / Revised: 21 December 2017 / Accepted: 25 December 2017 / Published: 27 December 2017
Invariant natural killer T (iNKT) cells are an “innate-like” T cell lineage that recognize glycolipid rather than peptide antigens by their semi-invariant T cell receptors. Because iNKT cells can stimulate an extensive array of immune responses, there is considerable interest in targeting these cells to enhance human vaccines against a wide range of microbial pathogens. However, long overlooked is the potential to harness iNKT cell antigens as vaccine adjuvants for domestic animal species that express the iNKT cell–CD1d system. In this review, we discuss the prospect of targeting porcine iNKT cells as a strategy to enhance the efficiency of swine influenza vaccines. In addition, we compare the phenotype and tissue distribution of porcine iNKT cells. Finally, we discuss the challenges that must be overcome before iNKT cell agonists can be contemplated for veterinary use in livestock. View Full-Text
Keywords: iNKT cells; CD1d; influenza vaccine; adjuvants; pig iNKT cells; CD1d; influenza vaccine; adjuvants; pig
Show Figures

Figure 1

MDPI and ACS Style

Yang, G.; Richt, J.A.; Driver, J.P. Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective. Int. J. Mol. Sci. 2018, 19, 68.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop